Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

NCT05513664 · clinicaltrials.gov ↗

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced or Metastatic Non-Small Cell Lung Cancer
EGFR Exon20 Insertion Mutations

Interventions

DRUG: Osimertinib

Sponsor

Shanghai JMT-Bio Inc.

Collaborators

[object Object]